Jove
Visualize
Contact Us

Related Experiment Videos

Treating hypertension in the elderly: protagonist viewpoint.

Michael A Weber1

  • 1State University of New York Downstate Medical College, USA. mweber@downstate.edu

The American Journal of Geriatric Cardiology
|November 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Systolic anterior motion of a retained anterior mitral valve leaflet following mitral valve replacement.

The American journal of geriatric cardiology·2008
Same journal

Biomarkers, age, and coronary artery remodeling in patients with acute coronary syndrome.

The American journal of geriatric cardiology·2008
Same journal

Electrocardiographic intervals in the healthy geriatric population--what are the "normals"?

The American journal of geriatric cardiology·2008
Same journal

Coronary events in persons aged 75 years or older in Finland from 1995 to 2002: the FINAMI study.

The American journal of geriatric cardiology·2008
Same journal

Sinus venosus atrial septal defect diagnosed at age 82.

The American journal of geriatric cardiology·2008
Same journal

Frailty, inflammation, and cardiovascular disease: evidence of a connection.

The American journal of geriatric cardiology·2008
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Treating systolic hypertension in older adults significantly reduces cardiovascular events like stroke and heart failure. Evidence supports treatment even for less severe hypertension stages, potentially benefiting dementia risk.

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease is a leading cause of death in the U.S.
  • Aging increases cardiovascular event risk, largely due to hypertension and diabetes.
  • Systolic hypertension, common in older adults, is a major risk factor for stroke and heart failure.

Purpose of the Study:

  • To evaluate the benefits of treating systolic hypertension in the elderly.
  • To assess the extrapolation of treatment benefits to less severe hypertension stages.
  • To review evidence for stroke and dementia prevention in older hypertensive patients.

Main Methods:

  • Analysis of clinical trial evidence on hypertension treatment in older adults.
  • Extrapolation of treatment guidelines from Stage 2 to Stage 1 systolic hypertension.

Related Experiment Videos

  • Review of studies focusing on octogenarians and treatment outcomes.

    • Main Results:

    • Treating elderly patients with hypertension significantly decreases cardiovascular events.
    • Evidence supports treating Stage 1 systolic hypertension by extrapolating from Stage 2 findings.
    • Strokes are demonstrably preventable in octogenarians through hypertension treatment.

    Conclusions:

    • Hypertension treatment is crucial for reducing cardiovascular risk in the elderly.
    • Benefits of treating systolic hypertension can be extrapolated to less severe cases.
    • Hypertension management in older adults may reduce dementia incidence, requiring further confirmation.